Otsuka Pharmaceutical Development & Commercialization, Inc.
Princeton, NJ, United States
This page shows every FDA and USDA recall linked to Otsuka Pharmaceutical Development & Commercialization, Inc.. Each entry includes the product involved, when the recall happened, and how serious it was. If a company has had multiple recalls over the years, you can see the full history here in one place — including whether any were Class I, which is the most serious type.
1
Total Recalls
2018
First Recall
2018
Most Recent
treatNOW ABILIFY (aripiprazole) and ABILIFY MAINTENA (aripiprazole) 400MG for extended release injectable susp...
Oct 10, 2018
· Drug
Class III
Terminated